Urinary LL-6/EGF ratio: A useful prognostic marker for the progression of renal damage in IgA nephropathy. Interleukin 6 (IL-6) is produced by human mesangial and tubular cells, and its urinary levels has been proposed as a marker of mesangial proliferation and tubulointerstitial damage. Epidermal growth factor (EGF) is expressed within the Henle's loop and the distal tubule and has been shown to accelerate recovery from renal injury. In the present study we have defined renal gene and protein expression of IL-6 and EGF in 10 normal, 10 nonproliferative glomerulonephritis (NPGN) and 30 IgA nephropathy (IgAN) human kidneys by RT-PCR, in situ hybridization and immunohistochemical techniques.
IgA nephropathy (IgAN) is a chronic mesangioproliferative glomerulonephritis (GN) characterized by the predominance of granular and electron dense deposits of IgA, and frequently, C3 in the glomerulus [1] . It has a variable course and leads to end-stage renal disease (ESRD) in a substantial number of cases [1] . Lee, Rao and Franklin [21 observed that histologic grading at the initial renal biopsy may be a useful prognostic indicator of the clinical outcome of IgAN. Indeed, it has been demonstrated that only patients with moderate to severe histologic lesions develop ESRD [1,21. In the recent years several lines of evidence have pointed out that histopathological changes within the tubulointerstitial compartment promote the progression of renal damage, regardless of its original disease process [reviewed in [3] [4] [5] [6] . The extent of the interstitial infiltrate, which consists largely of T cells and macrophages, correlates with the degree of functional impairment and is a good predictor of long-term prognosis [3] .
Several investigations showed that cultured tubular cells synthetize and secrete, both constitutively and inducibly, an array of peptides which stimulate cell trophism and proliferation (growth factors), chemoattraction (chemokines), and modulate vessel tone (vasoactive peptides) [reviewed in [4] [5] [6] [7] [8] [9] . Fine, Ong and Torman [5] hypothesized that protein overload in the glomerular ultrafiltrate or hypertension-induced microvascular ischemia may cause tubular injury, which in turn induces an up-or a down-regulation of the above peptides. Therefore, we decided to focus our attention on two cytokines, namely interleukin-6 (IL-6) and epidermal growth factor (EGF), that have been implicated in the progression of renal damage and in the repair process [10] [11] [12] [13] [14] [15] [16] [17] [18] .
At the renal level, glomerular mesangial and tubular epithelial cells express and secrete IL-6 [10, 19, 20] . Mesangial hyperproduction of IL-6, induced by phlogistic stimuli, seems to be responsible, at least in part, for the proliferative histologic lesions observed in mesangioproliferative GN [10] . Moreover, an increase in renal IL-6 expression and urine concentration correlate with mesangial proliferation, tubular atrophy and the intensity of interstitial cellular infiltrates, thus supporting a role for this cytokine in the progression of renal damage [10] [11] [12] [13] [14] [15] .
On the other hand, EGF produced by the ascending portion of Henle's loop and the distal convoluted tubule is a peptide that seems to modulate tissue repair [16] [17] [18] . A reduction of the renal EGF expression and its urinary concentration has been reported during acute tubular injury [21] [22] [23] [24] [25] [26] . Finally, a glomerular upregulation of EGF-receptor (EGF-R) occurs in human mesangioproliferative glomerulonephritis (MPGN), which indirectly suggests a pathogenetic involvement of the EGF/EGF-R loop in renal damage [27] .
In the present study we evaluated the renal gene expression and protein synthesis of IL-6 and EGF, and measured urinary IL-6 and EGF concentration in a chronic form of GN, namely IgAN. Furthermore, we correlated renal cytokine expression and urinary IL-6/EGF ratio with serological (serum creatinine), urinary (proteinuria), and histopathological (glomerular and tubular interstitial damage) findings of this disease.
into the study. Twenty healthy volunteers and 10 patients affected by nonproliferative GN (NPGN; 5 minimal change disease, 5 membranous nephropathy) strictly matched for sex and age were also recruited as controls. Diagnosis was made by renal biopsy and standard examination of the cortical tissue by light microscopy and immunofluorescence. As routinely performed in our institution, histologic diagnosis of IgAN was also supplemented with a grading of disease severity according to the classification in five classes described by Lee et a! [2] . Briefly, Grade I showed mild glomerular changes with occasional slight mesangial thickening (segmental) without hypercellularity and no tubulointerstitial changes (mild GN). In Grade II, glomerular changes showing localized mesangial proliferation and sclerosis were found in less than half of the glomeruli.
Small crescents were rarely observed and no tubulointerstitial changes were present (minor GN). Grade III was characterized by diffuse mesangial proliferation and thickening of the basal membrane with a focal and segmental distribution. Occasionally, small crescents and adhesions, as well as tubulointerstitial changes (focal interstitial edema and infiltrate) were observed. Tubular atrophy was rare (focal segmental GN). In Grade IV there was a marked diffuse mesangial proliferation and sclerosis. Crescents were present in up to 45% of glomeruli. Partial or total glomerulosclerosis was frequent. Tubular atrophy, interstitial inflammation and occasional interstitial foam cells were frequent findings (diffuse proliferative GN). Finally, Grade V was similar to Grade IV but the histologic lesions were more severe. Crescents were present in more than 45% of glomeruli (diffuse proliferative and scierosing GN). Conventionally, we defined the Grade 1-Grade 2 (G1-G2) classes as mild and nonprogressive disease, G3-G4 as moderate and potentially progressive disease, and G5 as severe and progressive disease.
Urine collection
At the time of biopsy, fresh urine samples were collected in the morning, centrifuged at 600 x g for five minutes and dialyzed thrice against sterile PBS for two hours at 4°C. Samples were harvested from dialysis tubes (MWCO 5,000, Spectrum, Los Angeles, CA, USA) and frozen at -20°C until tested, Urinary studies were performed in IgAN patients and normal controls.
None of them had urinary tract infection at the time of the study.
Renal studies
Thirty out of 41 renal biopsies from IgAN patients (13 patients were in classes G1-G2, 10 patients were grouped in classes G3-G4; 7 patients were in G5 class), 10 renal biopsies from patients affected by nonproliferative GN, and 10 normal-appearing portions of kidneys removed for renal carcinoma, were adequate for immunohistochemistry and in situ hybridization. Duplicate measurements of total renal cortex IL-6 mRNA were performed in 20 patients affected by IgAN (7 patients in classes G1-G2; 7 patients in classes G3-G4; 6 patients in the G5 class), as well as in 10 patients affected by NPGN and 10 normal appearing portion of kidneys removed for renal carcinoma.
Total RNA extraction
Kidney specimens from percutaneous biopsy or surgical nephrectomy were immediately frozen in liquid nitrogen until used. After taking cryostat sections for immunohistology and in situ hybridization studies, frozen renal cortex was lysed in 500 jLl of guanidine buffer and subsequently homogenized with an Ultra-Turrax T25 (Janke & Kunkel, Staufen, Germany). Total RNA was extracted by the single-step method, using phenol and chloroform! isoamylalcohol as previously described [28] , and then analyzed in denaturing gel of 1% agarose and 2.2 M formaldehyde in lx MOPS running buffer. All gels were stained with ethidium bromide to visualize 28S and 18S ribosomal RNA bands and to exclude degradation of RNA. Usually, 3 to 10 .rg of total RNA were obtained from each biopsy.
RT-PCR assay
One microgram of total RNA was reverse-transcribed into cDNA and then amplified by using the following set of primers specific for IL-6, EGF or GAPDH: IL-6 sense 5'-ATG AAC TCC TFC TCC ACA AGC GC-3' antisense 5'-GAA GAG CCC TCA GGC TGG ACT G-3' EGF sense 5' GAT GGG TAC TGC CTC CAT GAT GG-3' in a total volume of 50 d. The amplification profile involved denaturation at 95°C for 30 seconds, primer annealing and extension at 60°C for one minute. For semiquantitative analysis, aliquots (10 1itl) were taken after different numbers of cycles (20-30-40) to establish the amplification plateau. Thirty cycles was found to be the best amplification profile able to recognize differences between samples. Therefore, all samples were amplified for 30 cycles and then were electrophoresed in 1.5% agarose gels in Tris borate!EDTA buffer. Gels were stained with ethidium bromide and photographed. All signals obtained were normalized to the mRNA levels of GAPDH, a housekeeping gene, and expressed as a ratio.
Southern blot analysis
To confirm the specificity of PCR products, 1 d of the amplified cDNA was electrophoresed on 1.5% agarose gel, blotted onto a nylon membrane (Schleicher & Schuell, Dassel, Germany) and crosslinked by exposure to UV light. After prehybridization, the filter was hybridized with fluorescein labeled eDNA probes (ECL Random Prime Labeling System; Amersham, UK) specific for human IL-6, EGF or GAPDH. Hybridization was performed at 60°C in 5 X SSC, 0.1% SDS, 5% dextran sulphate and denatured salmon sperm DNA (100 pg/ml). Thereafter, the filter was washed once in 1 x SSC, 0.1% SDS and once in 0.5 X SSC, 0.1% SDS at 60°C for 15 minutes each. Following the stringency washes, the filter was blocked and incubated with horseradish peroxidase conjugate anti-fluorescein antibody. The blot was then covered with the detection buffer, containing luminol, and exposed for three minutes to Kodak X-omat X-ray film. The bands obtained were quantified by densitometric analysis.
Urinaiy IL-6 and EGF assay Quantitative determination of the IL-6 and EGF levels in urine was performed using a human interleukin-6 and a human EGF ELISA Kit (Biotrak; Amersham), a multiple-sandwich solidphase enzyme immunoassay that uses monoclonal and polyclonal antibodies raised against human IL-6 and EGF proteins. The enzymatic reaction was detected in an automatic microplate photometer (Titertek, Flow Labs, USA). The IL-6 and EGF concentration of the unknown samples were determined by interpolation into a standard curve developed with known amounts of purified human IL-6 and EGF proteins, and expressed in pg/mI. The lower detection limit was 0.7 pglml for IL-6 and 8 pg/ml for EGF. The intra-and interassay coefficients of variation were 4.2% and 7.0% for IL-6, and 2.9% and 4.1% for EGF, respectively.
In situ hybridization
Renal tissue was immediately included in OCT compound, snap-frozen in liquid nitrogen and stored in the same liquid until used. Frozen sections (6 j.tm thick) were collected onto polylysinecoated slides, dried briefly on a hot plate at +80°C and fixed in 4% paraformaldehyde for 20 minutes. After two washes in PBS, dehydration in graded ethanols and brief air drying, sections were immediately used for in situ hybridization. Sections from normal and diseased kidneys were processed in parallel, using the same batches of probes and reagents.
For the preparation of RNA probes, the cDNA fragments were subcloned into the plasmid pGEM1 (Promega Biotech, Florence, Italy) at the appropriate restriction sites. After linearization of the plasmids with either HindIII or EcoRI restriction endonuclease, T7 or SP6 RNA-polymerase (Boehringer Mannheim, Germany), respectively, were employed to obtain run off transcripts of either the anti-sense (complementary to mRNA) or sense (anticomplementary to mRNA, negative control) strands. Transcription and labeling of RNA probes were performed as described [29] . Briefly, 80 Ci of [35S]uridine-5'-(a-thio)-triphosphate (S.A. 1,250 Ci! mmol; Amersham) was added to a 10 d reaction mixture (0.5 mM each of adenosine-, cytidine-and guanosine-5'-triphosphate/l ms dithiothreitol/10 units human placental RNase inhibitor/6 mvi MgCl2/10 mr'i Tris-HCI, pH 7.5/2 mrvi spermidine/lO mivi NaCI) including 1 j.tg of linearized plasmid and 16 units of either SP6 or T7 RNA polymerase. The reaction was allowed to proceed for 60 minutes at 38°C. The DNA plasmid was removed by digestion with 25 j.g/ml RNase-free DNase I in a mixture containing 12.5 mg/ml of yeast tRNA and 10 units of RNase inhibitor for 10 minutes at 37°C. Free ribonucleotides were removed by phenolchloroform extraction followed by ethanol precipitation. To increase the penetration into tissue, the size of the 35S-labeled RNA probes was adjusted to 50 to 200 bases length by a controlled alkaline hydrolysis in 80 mi NaHCO3/120 mM Na2CO3, pH 10.2/10 mi dithiothreitol at 60°C. After neutralization in 0.2 M sodium acetate, pH 6.0/1% acetic acid/lO mrvi dithiothreitol and ethanol precipitation, RNA probes were stored at -80°C and used within four weeks. The specific activity usually obtained was 1.2 to 1.4 X i0 cpm/j.tg of 35S-labeled RNA probe. Prehybridization, hybridization, removal of a nonspecifically bound probe by RNase A digestion, and further washing procedures were performed for both positive and negative strand RNA probes as described previously [30, 3fl . Autoradiography was performed by dipping the dehydrated slides into Ilford G5 nuclear emulsion (Ilford, Mobberley Cheshire, UK). The exposed slides were developed using Kodak D19 developer (Kodak, Hemel Hampstead, UK), counterstained in hematoxylin-eosin and finally mounted.
Immunohistochemistiy
The immunohistochemical detection of IL-6 and EGF was performed on frozen kidney sections using chromatographically purified mouse antibody, specific for human IL-6 (Genzyme, Cambridge, MA, USA) and human EGF (IgGi, clone 144-8; Oncogene Science, Inc., Manhasset, NY, USA). Immobilized mouse antibodies were detected by the immunoalkaline phosphatase (APAAP) method with an affinity-purified rabbit antimouse immunoglobulin serum (1:20 dilution; Dako, Milan, Italy) and APAAP complex (1:50 dilution, Dako), as previously described [30, 31] . Alkaline phosphatase was developed with a mixture of naphtol AS-BI phosphate and new fuchsin (Sigma, Milan, Italy). Levamisole (Sigma, Munich, Germany) was added to the development solution in order to block endogenous alkaline phosphatase activity. Negative controls were performed by omitting the primary or secondary antibodies, and employing non-immune mouse serum as first layer. The identification of tubular segments were performed as follows: (1) for the proximal tubule, the presence of endogenous alkaline phosphatase was detected by using a mixture of naphtol AS-BI phosphate and new fuchsin lacking levamisole, while the CHIP28 antigen, a water channel protein [321 by an indirect immunofluorescence technique employing a rabbit polyclonal anti-human CHIP28 antibody (donated by Dr. G. Valenti) followed by a fluorescein-conjugated anti-rabbit antibody; (2) for the ascending portion of Henle's loop and the distal tubule, a direct immunofluorescence technique was employed using a fluoresceine-conjugate anti-human Tamm-Horsfall protein (provided by Dr. G.B. Fogazzi) [33] .
Microscopy studies
The histologic lesions and the optical density of the signals generated by the new fuchsin (immunohistochemistry) and silver grains (in situ hybridization) were quantitated by a computerbased morphometric analysis system. The video image was generated with a video camera (Hamamatsu, Milan, Italy) connected through a frame grabber (Hamamatsu) to a Power PC computer (Macintosh, Cupertino, CA, USA). Single images were digitized for image analysis at 256 grey levels. Imported data were analyzed quantitatively by an Optilab Pro 2.6.1 Software (Graftek, Villanterio, PV, Italy) that operated a color-based pitch densitometry. An optical threshold and filter combination was set to select only the nuclei, the mesangial matrix, the interstitial infiltrate and fibrosis, the new fuchsin deposits and silver grains. Two observers independently assessed morphological changes as well as in situ hybridization and immunohistochemical signals in a double-blind protocol, as previously described [31] .
Total area, glomerular matrix area, glomerular cellularity, number of interstitial cell infiltrates, areas of interstitial fibrosis and number of pixels generated by silver grains (in situ hybrid ization) and new fuchsin (immunohistochemistry) were quantified in 4'I'. .. five to eight randomly selected glomeruli or interstitial areas from each biopsy. The structures of interest were interactively discriminated by the operators using the cursor and then automatically measured for total area. The resulting counts divided by the total area gave the measures desired. Using the Statview II Software (Brain Power Inc., Calabasas, CA) the single data for each variable were tabulated and Pearson's correlation coefficient were computed by linear-least squares regression.
Statistical analysis
Quantitative data were compared among the groups by ANOVA, and multiple interferences were drawn by Fisher's protected t-test. The correlation coefficients are Pearson's r values.
Results
IgAN patients, as a whole, showed an increased expression of IL-6 niRNA by PCR in total renal cortex compared to normals and to patients affected by NPGN ( Fig. 1) . Specifically, the increase was remarkable only in those biopsies showing relevant signs of tubulointerstitial damage (tubular atrophy, cellular infiltrates). Indeed, patients with moderate-severe tubulointerstitial lesions (G3-G4 and G5 classes) had a 1.76-and 4.24-fold increase of IL-6 mRNA levels, respectively, compared to normals, whereas the IL-6/GAPDH ratio of G1-G2 patients did not differ from normals or from patients affected by NPGN (1.0, 1.3 and 0.90, respectively; Figs. 1 and 2) . It was interesting to observe that the • only NPGN patient (a case with membranous nephropathy) • displaying high mRNA levels of IL-6 ( Fig. 1 ) also had severe tubulointerstitial lesions and showed an unfavorable outcome at the follow-up.
To characterize the cellular source of IL-6 production, in situ hybridization coupled to immunohistochemistry were employed.
In normal appearing renal tissue, IL-6 niRNA and protein expression was faintly observed within some portions of tubules ( Figs. 3 and 4) . The IL-6 cRNA antisense probe and anti-IL-6 antibody did not label either the glomerulus or the vascular tree and the interstitium. By immunohistochemistry, IL-6 was mostly found intracellularly, with a diffuse intracytoplasmatic pattern. As demonstrated by endogenous alkaline phosphatase staining, the tubules expressing IL-6 were of proximal origin, while tubules positive for the Tamm-Horsfall protein (1-lenle's loop and distal convoluted tubules) turned out to be negative (data not shown).
IL-6 was up-regulated both at the transcriptional and posttranscriptional level in diseased kidneys ( Figs. 3 and 4 ). This increased gene and protein expression was found both at the tubular as well as at the interstitial level, particularly in areas of tubulointerstitial damage showing tubular atrophy and interstitial cellular infiltrates. Moreover, an intense gene and protein expression was also observed within glomeruli with segmental or diffuse histologic lesions, whereas IL-6 up-regulation was mainly located into the mesangial areas. A strict correlation was found between IL-6 gene and protein expression and the histological features of the disease (glomerular sclerosis, r = 0.5 16, P < 0.0005; mesangial proliferation, r = 0.513, P < 0.0006; tubular atrophy, r = 0.528, P < 0.0004; interstitial infiltrates, r = 0.530, P < 0.0004).
In NPGN, IL-6 gene and protein expression paralleled the pattern observed in normal kidneys, except for the patient showing high IL-6 mRNA levels in total cortex (Fig. 1) . Fifteen out of 41 urine samples of IgAN patients showed IL-6 moderate-severe forms of IgAN, although only patients with G5 levels higher than the normal range (mean 2 SD). All patients histologic grade reached levels statistically different from normals with NPGN but one displayed normal urinary levels of IL-6. and from patients affected by NPGN (Table 1) .
Urinary IL-6 concentrations were higher in patients affected by
In normal kidney, EGF gene and protein expression was mainly paralleled the degree of tuhulointerstitial damage (tubular atrophy, r = 0.663, P < 0.0001; interstitial infiltrates, r = 0.677, P < 0.0001). Interestingly, the NPGN patient with increased IL-6 expression showed also a low EGF expression. Moreover, while IgAN patients affected by G1-G2 histological classes showed an increase in urinary EGF concentration, patients with more severe histological lesions showed a statistically significant reduction compared to normals and to patients affected by NPGN ( Table 1 ). Table 2 , urinary IL-6/EGF ratio allowed to discriminate patients with progressive disease from those with a stable clinical course over a 36 month follow-up. Specifically, patients with a urinary IL-6/EGF ratio higher than I showed a worse evolution compared to patients with a ratio lower than I ( Fig. 7) . Finally, urinary IL-6IEGF ratio correlated with the histological grading and the presence of hypertension, but not with proteinuria (Table 3) .
As shown in

Discussion
In the present study, we investigated the pathogenetic involvement of two cytokines, IL-6 and EGF, in a chronic form of glomerulonephritis, IgAN. IL-6 is a multifunctional cytokine, produced by a variety of cell types, which is able to exert its effects on infiltrated inflammatory cells as well as on structural cells in tissues [34] [35] [36] . Besides blood cells (T cells and macrophages), several normal as well as transformed cells of epithelial origin, have been reported to produce IL-6 upon appropriate stimulation in vivo and in vitro [34] [35] [36] . Interleukin-6 (IL-6) has been implicated in the injury process [34, 35] as a cytokine able to regulate the inflammatory and immune reaction and to stimulate proliferation of a variety of cell types [34] [35] [36] . Moreover, an abnormal expression of IL-6 has been documented in several diseases such as psoriasis, rheumatoid arthritis, Castleman' disease, AIDS, alcoholic liver cirrhosis, and cardiac myxoma [37] [38] [39] [40] [41] [42] . The kidney represents the main source of EGF, which is chiefly produced by the ascending portion of Henle's loop and by the distal convoluted tubule, and seems to play an important role in modulation of glomerular hemodynamics, activation of renal the maintenance of renal tubular trophism and in the recovery metabolism, changes in tubular transport and eicosanoid synthesis from acute tubular injury [16] [17] [18] [43] [44] [45] . An array of renal [46] [47] [48] [49] [50] [51] [52] [53] [54] . In addition, EGF may direct renal cell proliferation responses are elicited by systemic administration of EGF such as during fetal life [55] . Although several studies have demonstrated Abbreviations are: TX, transplantation; HD, hemodialysis; P, proteinuria; H, hypertension (1, absent; 2, present). A total of 33 patients concluded the 36 month follow-up (T36). Three patients were lost at the 12 month follow-up (LF), and the remaining 5 patients are still in the first 12 months of follow-up.
the pathogenetic involvement of EGF in acute forms of renal damage [21] [22] [23] [24] [25] , data regarding its importance in chronic forms are still lacking.
In agreement with Horii and coworkers and Fukatsu et al [10] [11] [12] , we found an increase of renal IL-6 mRNA expression and urinary IL-6 concentration in patients affected by moderate to severe histologic forms of IgAN compared to patients with mild histological lesions, NPGN, and normals. Moreover, to our knowledge we report here, for the first time, that there also is an increase of IL-6 gene expression. Taken together, these data suggest that in moderate to severe forms of IgAN an upregulation of IL-6 occurs bt)th at the transcriptional and posttranscriptional level. The increased renal IL-6 mRNA and protein expression, and the urinary IL-6 concentration correlated with the degree of the histological lesions, and particularly with the severity of tubulointerstitial damage (interstitial fibrosis, cellular infiltrates, and tubular atrophy) and the grade of glomerular sclerosis. In situ hybridization and immunohistochemistry studies revealed that IL-6 was expressed and produced by mesangial and proximal tubular cells, as well as by infiltrating cells (monocytes and lymphocytes). The latter finding may account for the reported increase of urinary IL-6 concentration in those forms of renal tubulointerstitial damage lacking a glomerular involvement, such as acute renal allograft rejection and acute pyelonephritis [13, 561. In this setting, it is of note that among patients with NPGN an increase of rcnal IL-6 expression was observed only in one case showing a severe tubulointerstitial damage. Similarly, Ohta et al [13] found high levels of urinary IL-6 in patients affected by Kawasaki's disease, which is characterized by mesangial hypercellularity associated with an impressive interstitial infiltrate of lymphocytes and giant mononuclear cells. Moreover, Frank et a! [20] demonstrated that renal tubular epithelial cells and interstitial fibroblasts from normal and diseased kidneys express specific IL-6 transcripts. Interestingly, Duncan and Berman [57] and Sato, Ito and Mon [58] described that, upon IL-6 stimulation, interstitial fibroblasts are able to produce extracellular matrix components as well as a tissue inhibitor of metalloproteinases. These studies, coupled to our data, support the hypothesis that the release of IL-6 by cellular infiltrates (lymphocytes and macrophages), renal epithelial cells and interstitial fibroblasts may act, both in an autocrine and in a paracrine fashion, on renal fibroblasts stimulating cell proliferation and the production of collagen, which eventually lead to renal interstitial fibrosis. Addi-tionally, locally-produced IL-6 may activate the cellular infiltrate, thus playing an additional role in the induction of injury [121.
In parallel with the up-regulation of IL-6 expression in moderate to severe histological forms of lgAN, we observed, for the first time, a down-regulation of EGF expression both at the transcriptional and post-transcriptional levels, which strictly correlated with urinary EGF concentration. Data from experimental models demonstrate that acute glomerular and tubular injury causes a transient down-regulation of EGF expression, which thereafter returns to normal or even supernormal levels in the recovery phase [21] [22] [23] [24] [25] [26] . These last findings may explain the increased urinary EGF concentration observed in G1-G2 classes of IgAN, which by definition are mild histological forms of IgAN, and why these patients do not develop ESRD but are in a "chronic recovery state." Recently, we were able to reveal, in agreement with other authors, a dramatic decrease of EGF mRNA and protein expression as well as of its urinary concentration in patients with acute tubulointerstitial damage, which supports a role for the growth factor in the pathogenesis of acute tubulointerstitial injury in humans [24, 25] . The present investigation expands the role of EGF to the pathogenesis of chronic renal injury observed in human IgAN. Presently, we cannot distinguish between a down-regulation of EGF gene expression induced by chronic tubulointerstitial injury on functional tubular cells and/or a direct effect of cell loss and tubular atrophy. Nonetheless, we speculate that the same event, namely chronic ischemic injury or tubular protein overload, may stimulate IL-6 synthesis while depressing EGF expression. As a consequence, these variations in cytokine production would determine an alteration of tubular epithelial trophism as well as an increase of interstitial fibrosis, and thus would induce the progression of chronic tubulointerstitial damage towards sclerosis.
Urinary concentration of EGF and IL-6 was found to mirror the modifications of their renal expression and to correlate with the severity of tubulointerstitial damage. Furthermore, having a urinary IL-6/EGF ratio at the time of renal biopsy permitted us to discriminate between those patients with a progressive disease from those with a stable clinical course over a 36 month follow-up.
In conclusion, in the present study we report that chronic tubulointerstitial damage, as observed in a mesangioproliferative glomerulonephritis such as IgAN, is accompanied by a decrease of tubular EGF gene and protein expression and an up-regulation of IL-6, which strictly correlate with the degree of tubulointerstitial involvement. Finally, we present evidence that urinary IL-6/EGF ratio may be, in chronic forms of renal damage, a feasible prognostic indicator of renal progression towards sclerosis. 
